Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Titan Pharmaceuticals Inc.

www.titanpharm.com

Latest From Titan Pharmaceuticals Inc.

Keeping Track: An RMAT, Two QIDPs, And Some Bad News Too

The latest drug development news and highlights from our FDA Performance Tracker.

Drug Review Regulation

Indivior To Appeal US Suboxone Setback, Flags Follow-On Drug RBP-6000

Shares in Indivior slid nearly 40% on news of a US court ruling which raises chances its key opioid addiction treatment may face generic competition sooner than expected.

Business Strategies Companies

Deals Shaping the Medical Industry, August 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced July 2017.

Deals BioPharmaceutical

Keeping Track: Merck's Follow-On Insulin Edges Closer To Market; Braeburn Submits Another Buprenorphine Depot

The latest drug development news and highlights from our FDA Performance Tracker.

Approvals Review Pathway
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Titan Pharmaceuticals Inc.
  • Senior Management
  • Sunil Bhonsle, Pres.
    Katherine L Beebe, PhD, EVP & Chief Dev. Officer
  • Contact Info
  • Titan Pharmaceuticals Inc.
    Phone: (650) 244-4990
    400 Oyster Point Blvd.
    Ste. 505
    S. San Francisco, CA 94080-1921
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register